Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04993261 · ClinicalTrials.gov registry record · Early Phase 1
An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors
A Early Phase 1 study of Carcinoid Tumor and Carcinoid Syndrome, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- Early Phase 1
- Development phase
- 71
- Enrollment target
- 1
- Study location
NCT04993261 is a Early Phase 1 study of Carcinoid Tumor and Carcinoid Syndrome that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 71 participants, below the 90-participant average among 8 other Carcinoid Tumor trials with a reported enrollment target (21% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04993261, a Early Phase 1 study of Carcinoid Tumor and Carcinoid Syndrome, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 71 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies the use of a special type of computed (CT) scan called dual energy CT in detecting gastrointestinal carcinoid tumors. CT is an imaging technique that uses x-rays and a computer to create images of areas inside the body. Dual energy computed tomography is a technique used during routine CT scans to help obtain and process the image after the scan is complete. Doctors want to learn if dual energy computed tomography can help improve the detection of carcinoid tumors during routine CT scans.
Conditions Studied
Interventions
- PROCEDURE Dual-Energy Computed Tomography
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2015-09-23 |
| Est. Completion | 2026-12-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04993261
The ClinicalTrials.gov registry entry for NCT04993261 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 90-participant average among 8 other Carcinoid Tumor trials with a reported enrollment target (21% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Carcinoid Tumor appearing as the primary indexed condition, and to 1 intervention - of which Dual-Energy Computed Tomography is the first listed.
NCT04993261 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04993261 about?
NCT04993261 is a clinical study titled "An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors". This trial studies the use of a special type of computed (CT) scan called dual energy CT in detecting gastrointestinal carcinoid tumors. CT is an imaging technique that uses x-rays and a computer to create images of areas inside the body. Dual energy computed tomography is a technique used during ro...
What is the current status of trial NCT04993261?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 71 participants. The study started on 2015-09-23. Estimated completion is 2026-12-31.
What conditions does trial NCT04993261 study?
This clinical trial studies the following conditions: Carcinoid Tumor, Carcinoid Syndrome, Digestive System Neuroendocrine Tumor G1, Metastatic Carcinoid Tumor.
What interventions are being tested in trial NCT04993261?
The interventions under investigation include: Dual-Energy Computed Tomography (PROCEDURE).
Who is sponsoring clinical trial NCT04993261?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04993261 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carcinoid Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
RECRUITING · Phase 2
-
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
RECRUITING · Phase 3
-
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
RECRUITING · Phase 3
-
AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors
COMPLETED · Phase 2
-
Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
COMPLETED · Phase 2
-
Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.